Literature DB >> 27809682

Human Immunodeficiency Virus-1 Impairs IFN-Alpha Production Induced by TLR-7 Agonist in Plasmacytoid Dendritic Cells.

Ashwini Dhamanage1, Madhuri Thakar1, Ramesh Paranjape1.   

Abstract

Plasmacytoid dendritic cells (pDCs) play an important role in innate immune response against viruses, mainly through interferon-α (IFN-α) secretion. Impaired IFN-α secretion has been observed in patients with acute human immunodeficiency virus type 1 (HIV-1) infection and the reasons for this impairment are still obscure. To know the grounds behind this situation, HIV-1 viral copy numbers similar to those found in primary HIV-1 infection were used to stimulate peripheral blood mononuclear cells (PBMCs) and pDCs in this study. Intracellular IFN-α production was seen as early as 2 h in pDCs with TLR-7 agonist (imiquimod) stimulation, but HIV-1 required 48 h to induce secretion of IFN-α in supernatants and it was 10 times less compared to imiquimod. Thus, it shows that HIV-1 delays and impairs IFN-α production from pDCs. Furthermore, the IFN-α inhibitory activity of HIV-1 was checked by stimulating PBMCs and pDCs with imiquimod either simultaneously with HIV-1 or after 2 h pre-exposure to HIV-1. Pre-exposure to HIV-1 resulted in significant reduction in IFN-α secretion by pDCs and PBMCs when compared to imiquimod alone. In addition, simultaneous stimulation of these populations with HIV-1 and imiquimod resulted in significant impairment in IFN-α production in pDCs but not in PBMCs. HIV-1 not only fails to induce IFN-α in adequate quantities but also inhibits IFN-α secretary capacity of pDCs. HIV-1 particles were found to bind CD303 receptor on pDC surface probably blocking initiation of cascade leading to IFN-α impairment. The understanding of the pathways that lead to this suppression may help in devising the HIV control strategies.

Entities:  

Keywords:  innate immunity; interferons

Mesh:

Substances:

Year:  2016        PMID: 27809682     DOI: 10.1089/vim.2016.0084

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  4 in total

1.  Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruption.

Authors:  Julie L Mitchell; Hiroshi Takata; Roshell Muir; Donn J Colby; Eugène Kroon; Trevor A Crowell; Carlo Sacdalan; Suteeraporn Pinyakorn; Suwanna Puttamaswin; Khunthalee Benjapornpong; Rapee Trichavaroj; Randall L Tressler; Lawrence Fox; Victoria R Polonis; Diane L Bolton; Frank Maldarelli; Sharon R Lewin; Elias K Haddad; Praphan Phanuphak; Merlin L Robb; Nelson L Michael; Mark de Souza; Nittaya Phanuphak; Jintanat Ananworanich; Lydie Trautmann
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

Review 2.  Human Immunodeficiency Virus 1 and Type I Interferons-Where Sex Makes a Difference.

Authors:  Susanne Maria Ziegler; Marcus Altfeld
Journal:  Front Immunol       Date:  2017-09-28       Impact factor: 7.561

3.  Therapeutic effect of imiquimod on dextran sulfate sodium-induced ulcerative colitis in mice.

Authors:  Lu Chen; Zhongyin Zhou; Yan Yang; Na Chen; Hongyu Xiang
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

Review 4.  The Role of Toll-Like Receptors in Retroviral Infection.

Authors:  Edward P Browne
Journal:  Microorganisms       Date:  2020-11-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.